Cargando…

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication

Quinolone has the disadvantage of easily acquired drug resistance. It is important to prescribe it wisely for a high eradication rate. The current study aimed to determine the clinical and bacteriological factors for optimal levofloxacin-containing triple therapies in second-line H. pylori eradicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Wei-Chen, Lee, Chen-Hsiang, Chiou, Shue-Shian, Kuo, Chung-Mou, Kuo, Chung-Huang, Liang, Chih-Ming, Lu, Lung-Sheng, Chiu, Chien-Hua, Wu, Keng-Liang, Chiu, Yi-Chun, Hu, Tsung-Hui, Chuah, Seng-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139398/ https://www.ncbi.nlm.nih.gov/pubmed/25141137 http://dx.doi.org/10.1371/journal.pone.0105822

Ejemplares similares

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
por: Tai, Wei-Chen, et al.
Publicado: (2013)

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2015)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
por: Yao, Chih-Chien, et al.
Publicado: (2019)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
por: Yun, Sang-Pil, et al.
Publicado: (2012)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study
por: Chang, Yang-Pei, et al.
Publicado: (2013)

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance
por: Huang, Tzu-Hsin, et al.
Publicado: (2021)

The Effect of Helicobacter pylori Eradication on the Levels of Essential Trace Elements
por: Wu, Meng-Chieh, et al.
Publicado: (2014)

Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori
por: El-Zahaby, Sally A., et al.
Publicado: (2014)

Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance
por: Miftahussurur, Muhammad, et al.
Publicado: (2019)

The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009)

Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
por: Song, Zhiqiang, et al.
Publicado: (2019)

Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial
por: Alavinejad, Pezhman, et al.
Publicado: (2023)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
por: Kuo, Chung-Mou, et al.
Publicado: (2019)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
por: Chen, Ming-Cheh, et al.
Publicado: (2014)

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
por: Basu, P Patrick, et al.
Publicado: (2011)

Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
por: Silva, Fernando Marcuz, et al.
Publicado: (2015)

Levofloxacin based vs clarithromycin based sequential therapy in helicobacter pylori eradication; a randomized clinical trial
por: Moradniani, Mosayeb, et al.
Publicado: (2018)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract of Adults
por: Yao, Chih-Chien, et al.
Publicado: (2015)

Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint
por: Zamani, Mohammad, et al.
Publicado: (2017)

First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
por: Zullo, Angelo, et al.
Publicado: (2014)

Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial
por: Sebghatollahi, Vahid, et al.
Publicado: (2018)

The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2022)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Novel Low-Cost Endoscopic Cap for Esophageal Foreign Objects: A Case Report
por: Chiu, King-Wah, et al.
Publicado: (2015)

Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori
por: Hanafi, Aimi, et al.
Publicado: (2016)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
por: Wu, Meng-Chieh, et al.
Publicado: (2017)

Response to “Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial”
por: Patil, Anant D
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5fpa5tuprvmoee9t6ibb1dekhb